欣笑安品牌怎么样 申请店铺

我要投票 欣笑安在成人用品行业中的票数:598 更新时间:2026-01-24
欣笑安是哪个国家的品牌?「欣笑安」是 安徽深蓝医疗科技股份有限公司 旗下著名品牌。该品牌发源于安徽省合肥市,由创始人张超在2010-02-04期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力欣笑安品牌出海!将品牌入驻外推网,定制欣笑安品牌推广信息,可以显著提高欣笑安产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

欣笑安怎么样

安徽深蓝医疗科技股份有限公司(以下简称“深蓝医疗”),安徽省内专业从事计生用诊断试剂及生物原料研发、生产和销售为一体的新型生物科技企业。

深蓝医疗拥有一支以医药生物学博士为主体的专业科研团队,与国内外科研机构建立了广泛的项目合作关系,具有生产医疗器械、体外诊断试剂等的研发与创新能力,拥有国内的生产设备和很高的技术力量。在胶体金标记技术、单克隆抗体、多克隆抗体、基因重组抗原、合成抗原等生物原料技术以及免疫层析技术等前沿生物领域的研究方面处于省内、国内较高水平。

经营销售的原料所涉及的领域包括:妊娠检测类、传染病检测类、食品安全类、毒品检测类、实验室耗材等,公司还销售与胶体金诊断试剂生产所需的多种设备、原材料,并提供多方位的技术支持。

深蓝医疗目前拥有诊断试剂生产线,应用新临床检验技术,具有操作简单、正确、及时方便等优点,其技术性能达到国内水平。已通过药监局质量体系考核,建立了YY/T0287—2003ISO13485:2003质量管理体系,企业产品分妇科、孕产和消化内科两大类。目前主要生产产品有胎膜早破检测试剂盒、妇科阴道病检查系列试剂盒、隐血系列检测试剂盒、传染病类检测试剂盒、腔道用医用超声耦合剂、LH(排卵)检测试纸、HCG(早孕)检测试纸等系列产品。同时经营相关抗体抗原产品,提供免疫诊断试剂盒技术服务,包括抗体抗原纯化处理、胶体金标记、实验室配备及生产线建设的全套咨询服务。

深蓝医疗现有商标及品牌:深蓝、欣笑安。


Anhui Shenlan Medical Technology Co., Ltd. (hereinafter referred to as "Shenlan medical") is a new type of biotechnology enterprise specialized in research and development, production and sales of family planning diagnostic reagents and biological raw materials in Anhui Province. Shenlan medical has a professional scientific research team with doctor of medical biology as the main body, has established a wide range of project cooperation relations with domestic and foreign scientific research institutions, has the research and development and innovation ability to produce medical devices, in vitro diagnostic reagents, etc., and has domestic production equipment and high technical force. The research of gold labeling technology, monoclonal antibody, polyclonal antibody, gene recombinant antigen, synthetic antigen and immunochromatography is at a high level in the province and China. The raw materials for operation and sales include: pregnancy testing, infectious disease testing, food safety, drug testing, laboratory consumables, etc. the company also sells a variety of equipment and raw materials required for the production of colloidal gold diagnostic reagents, and provides multi-directional technical support. At present, Shenlan medical has the production line of diagnostic reagents and the application of new clinical testing technology. It has the advantages of simple operation, correct, timely and convenient, and its technical performance has reached the domestic level. The quality management system of YY / t0287-2003iso13485:2003 has been established through the quality system assessment of drug administration. The products of the enterprise are divided into two categories: Gynecology, maternity and digestive medicine. At present, the main products include Prom test kit, gynecological vaginal disease test kit, occult blood test kit, infectious disease test kit, medical ultrasound couplant for cavity, LH (ovulation) test paper, HCG (early pregnancy) test paper and other series of products. At the same time, we are engaged in related antibody antigen products and provide technical services for immunodiagnostic kits, including antibody antigen purification and treatment, colloidal gold labeling, laboratory equipment and full set of consulting services for production line construction. Existing trademarks and brands of Shenlan medical: Shenlan, xinxiaoan.

本文链接: https://brand.waitui.com/db47843e8.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

美股大型科技股盘前涨跌不一,Arm涨超2%

36氪获悉,美股大型科技股盘前涨跌不一,截至发稿,Arm涨超2%,英伟达涨超1%,谷歌涨0.1%,微软涨0.06%;特斯拉跌0.17%,奈飞跌0.11%,亚马逊跌0.07%,苹果跌0.03%。

2小时前

热门中概股美股盘前涨跌互现,阿里巴巴跌超1%

36氪获悉,热门中概股美股盘前涨跌互现,截至发稿,阿里巴巴、京东跌超1%,小鹏汽车跌近1%,网易跌0.48%,蔚来跌0.21%;百度涨超1%,拼多多涨0.75%,理想汽车涨0.42%,B站涨0.09%。

2小时前

晶升股份:拟购买为准智能100%股份,交易作价8.57亿元

36氪获悉,晶升股份公告,公司拟通过发行股份及支付现金的方式购买本尚科技等10名交易对方持有的为准智能100%股份,同时募集配套资金。为准智能100%股份的交易作价为8.57亿元。本次交易构成关联交易和重大资产重组,但不构成重组上市。交易完成后,为准智能将成为上市公司控股子公司。

2小时前

天合光能:将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”

36氪获悉,天合光能公告,公司拟缩减“年产35GW直拉单晶项目”的募集资金投资金额,不再实施二期15GW项目,并将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”。新项目预计2026年底建成并投入运营。公司表示,本次变更有利于提高募集资金使用效率,合理优化资源配置,巩固市场地位,不会对公司正常经营产生不利影响。该事项尚需提交公司股东会和债券持有人会议审议通过后方可实施。

2小时前

宝洁第二财季净销售额222亿美元,同比增长1%

当地时间1月22日,宝洁公司发布2026财年第二季度(2025年10-12月)财报。财报显示,第二财季净销售额为222亿美元,同比增长1%;摊薄后每股净收益为1.78美元,同比下降5%。该公司维持2026财年总销售额同比增长1%至5%的指引区间,将2026财年摊薄后每股净收益增长指引从原先的3%-9%调整至1%-6%。(界面)

2小时前

本页详细列出关于欣笑安的品牌信息,含品牌所属公司介绍,欣笑安所处行业的品牌地位及优势。
咨询